BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

276 related articles for article (PubMed ID: 25114547)

  • 1. Contrast-enhanced magnetic resonance imaging in pediatric patients: review and recommendations for current practice.
    Bhargava R; Hahn G; Hirsch W; Kim MJ; Mentzel HJ; Olsen OE; Stokland E; Triulzi F; Vazquez E
    Magn Reson Insights; 2013; 6():95-111. PubMed ID: 25114547
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intravenous gadolinium-based hepatocyte-specific contrast agents (HSCAs) for contrast-enhanced liver magnetic resonance imaging in pediatric patients: what the radiologist should know.
    Ayyala RS; Anupindi SA; Gee MS; Trout AT; Callahan MJ
    Pediatr Radiol; 2019 Sep; 49(10):1256-1268. PubMed ID: 31350632
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Trial design and reporting standards for intra-arterial cerebral thrombolysis for acute ischemic stroke.
    Higashida RT; Furlan AJ; Roberts H; Tomsick T; Connors B; Barr J; Dillon W; Warach S; Broderick J; Tilley B; Sacks D; ;
    Stroke; 2003 Aug; 34(8):e109-37. PubMed ID: 12869717
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Survey of gadolinium-based contrast agent utilization among the members of the Society for Pediatric Radiology: a Quality and Safety Committee report.
    Blumfield E; Moore MM; Drake MK; Goodman TR; Lewis KN; Meyer LT; Ngo TD; Sammet C; Stanescu AL; Swenson DW; Slovis TL; Iyer RS
    Pediatr Radiol; 2017 May; 47(6):665-673. PubMed ID: 28283728
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Safety of gadobutrol in more than 1,000 pediatric patients: subanalysis of the GARDIAN study, a global multicenter prospective non-interventional study.
    Glutig K; Bhargava R; Hahn G; Hirsch W; Kunze C; Mentzel HJ; Schaefer JF; Willinek W; Palkowitsch P;
    Pediatr Radiol; 2016 Aug; 46(9):1317-23. PubMed ID: 27041276
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cardiac magnetic resonance imaging for the diagnosis of coronary artery disease: an evidence-based analysis.
    Medical Advisory Secretariat
    Ont Health Technol Assess Ser; 2010; 10(12):1-38. PubMed ID: 23074389
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical Efficacy of Reduced-Dose Gadobutrol Versus Standard-Dose Gadoterate for Contrast-Enhanced MRI of the CNS: An International Multicenter Prospective Crossover Trial (LEADER-75).
    Liu BP; Rosenberg M; Saverio P; Weon YC; Peters S; Ardellier FD; Boeckenhoff A; Endrikat J
    AJR Am J Roentgenol; 2021 Nov; 217(5):1195-1205. PubMed ID: 34133205
    [No Abstract]   [Full Text] [Related]  

  • 8. Gadolinium-based contrast agents in pediatric magnetic resonance imaging.
    Gale EM; Caravan P; Rao AG; McDonald RJ; Winfeld M; Fleck RJ; Gee MS
    Pediatr Radiol; 2017 May; 47(5):507-521. PubMed ID: 28409250
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of Unenhanced T1-Weighted Signal Intensities Within the Dentate Nucleus and the Globus Pallidus After Serial Applications of Gadopentetate Dimeglumine Versus Gadobutrol in a Pediatric Population.
    Renz DM; Kümpel S; Böttcher J; Pfeil A; Streitparth F; Waginger M; Reichenbach JR; Teichgräber UK; Mentzel HJ
    Invest Radiol; 2018 Feb; 53(2):119-127. PubMed ID: 28976476
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ESUR/ESUI consensus statements on multi-parametric MRI for the detection of clinically significant prostate cancer: quality requirements for image acquisition, interpretation and radiologists' training.
    de Rooij M; Israël B; Tummers M; Ahmed HU; Barrett T; Giganti F; Hamm B; Løgager V; Padhani A; Panebianco V; Puech P; Richenberg J; Rouvière O; Salomon G; Schoots I; Veltman J; Villeirs G; Walz J; Barentsz JO
    Eur Radiol; 2020 Oct; 30(10):5404-5416. PubMed ID: 32424596
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Optimizing contrast-enhanced magnetic resonance imaging characterization of brain metastases: relevance to stereotactic radiosurgery.
    Anzalone N; Essig M; Lee SK; Dörfler A; Ganslandt O; Combs SE; Picozzi P
    Neurosurgery; 2013 May; 72(5):691-701. PubMed ID: 23381488
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Consensus report from the 9
    Koh DM; Ba-Ssalamah A; Brancatelli G; Fananapazir G; Fiel MI; Goshima S; Ju SH; Kartalis N; Kudo M; Lee JM; Murakami T; Seidensticker M; Sirlin CB; Tan CH; Wang J; Yoon JH; Zeng M; Zhou J; Taouli B
    Eur Radiol; 2021 Aug; 31(8):5615-5628. PubMed ID: 33523304
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Transatlantic Recommendations for Prostate Gland Evaluation with Magnetic Resonance Imaging After Focal Therapy (TARGET): A Systematic Review and International Consensus Recommendations.
    Light A; Mayor N; Cullen E; Kirkham A; Padhani AR; Arya M; Bomers JGR; Dudderidge T; Ehdaie B; Freeman A; Guillaumier S; Hindley R; Lakhani A; Pendse D; Punwani S; Rastinehad AR; Rouvière O; Sanchez-Salas R; Schoots IG; Sokhi HK; Tam H; Tempany CM; Valerio M; Verma S; Villeirs G; van der Meulen J; Ahmed HU; Shah TT
    Eur Urol; 2024 May; 85(5):466-482. PubMed ID: 38519280
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of gadoteric acid and gadobutrol for detection as well as morphologic and dynamic characterization of lesions on breast dynamic contrast-enhanced magnetic resonance imaging.
    Renz DM; Durmus T; Böttcher J; Taupitz M; Diekmann F; Huppertz A; Pfeil A; Maurer MH; Streitparth F; Bick U; Hamm B; Fallenberg EM
    Invest Radiol; 2014 Jul; 49(7):474-84. PubMed ID: 24637587
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy and Safety of Half-Dose Gadopiclenol versus Full-Dose Gadobutrol for Contrast-enhanced Body MRI.
    Kuhl C; Csőszi T; Piskorski W; Miszalski T; Lee JM; Otto PM
    Radiology; 2023 Jul; 308(1):e222612. PubMed ID: 37462494
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnostic value of gadobutrol versus gadopentetate dimeglumine in enhanced MRI of brain metastases.
    Fan B; Li M; Wang X; Xu Y; Li F; Zhang L; Jiang J; Jiang Y
    J Magn Reson Imaging; 2017 Jun; 45(6):1827-1834. PubMed ID: 27696616
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Positron emission tomography for the assessment of myocardial viability: an evidence-based analysis.
    Medical Advisory Secretariat
    Ont Health Technol Assess Ser; 2010; 10(16):1-80. PubMed ID: 23074393
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Consensus Guidelines of the French Society of Neuroradiology (SFNR) on the use of Gadolinium-Based Contrast agents (GBCAs) and related MRI protocols in Neuroradiology.
    Lersy F; Boulouis G; Clément O; Desal H; Anxionnat R; Berge J; Boutet C; Kazémi A; Pyatigorskaya N; Lecler A; Saleme S; Edjlali-Goujon M; Kerleroux B; Ben Salem D; Kremer S; Cotton F
    J Neuroradiol; 2020 Nov; 47(6):441-449. PubMed ID: 32565280
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Do we need gadolinium-based contrast medium for brain magnetic resonance imaging in children?
    Dünger D; Krause M; Gräfe D; Merkenschlager A; Roth C; Sorge I
    Pediatr Radiol; 2018 Jun; 48(6):858-864. PubMed ID: 29623352
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 14.